9 , e1003401 (2013)
J Agric Food Chem 60:1057210577
BPC-157 & Wound Healing Skin, Burns, Diabetic Ulcers & Fistulas (PMC, 2021) A comprehensive wound healing review published in Frontiers in Pharmacology documented BPC-157s practical applicability across skin wound types incisional, excisional, deep burns, diabetic ulcers, alkali burns, and fistula healing confirming equivalent efficacy regardless of route of application (systemic or local) and across the same dose range
TB-500 protocol considerations Reported dosing in the research literature: Starting dose: 500 mcg daily, subcutaneous injection Titration: Increase by 100 to 150 mcg every two weeks as tolerated Target dose: 750 to 1000 mcg daily by weeks five through twelve Weekly total: Approximately 5 mg per week at full dose Cycle length: Eight to twelve weeks, with optional extension to sixteen weeks TB-500 is typically administered once daily via subcutaneous injection, with consistent timing and systematic site rotation
[PMC free article] [PubMed] [Google Scholar] [58].Mallick IH, Yang W, Winslet MC, Seifalian AM
